Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 19, 2014

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

- All six trials met primary efficacy endpoint -
Oct 28, 2014

Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER
- Photos 1
Oct 20, 2014

Sanofi and Regeneron Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis
Oct 15, 2014

New Survey Finds Differences In Attitudes About Diabetes Based On Age
Sep 17, 2014

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments -
- Photos 1

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.